| Peter J Parker, MD | |
|
1100 W Glenoaks Blvd, Glendale, CA 91202-2606 | |
| (818) 546-2626 | |
| (818) 546-1056 |
| Full Name | Peter J Parker |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 45 Years |
| Location | 1100 W Glenoaks Blvd, Glendale, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598783789 | NPI | - | NPPES |
| 00A449240 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | A44924 (California) | Primary |
| Entity Name | Peter Parker Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184721284 PECOS PAC ID: 5698745453 Enrollment ID: O20040728001595 |
News Archive
MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.
Cardiovascular disease (CVD) is the major cause of death among middle-aged adults around the world; however, in high-income countries deaths from cancer have become twice as frequent as those from CVD.
"We have analysed emotional traits of low intensity. In this context, the higher the negative emotional traits are, the fewer risks taken by the bodies managed by the directors", Juan Bautista Delgado Garc-a, co-author of the study and researcher at UBU declares to SINC.
Topshop is delighted to announce its continued support of charity initiative Fashion Targets Breast Cancer this year with the launch of a limited edition t-shirt, available online and instore nationwide.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
› Verified 3 days ago
| Entity Name | Glenoaks Urgent Care Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013097120 PECOS PAC ID: 9931269628 Enrollment ID: O20081126000112 |
News Archive
MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.
Cardiovascular disease (CVD) is the major cause of death among middle-aged adults around the world; however, in high-income countries deaths from cancer have become twice as frequent as those from CVD.
"We have analysed emotional traits of low intensity. In this context, the higher the negative emotional traits are, the fewer risks taken by the bodies managed by the directors", Juan Bautista Delgado Garc-a, co-author of the study and researcher at UBU declares to SINC.
Topshop is delighted to announce its continued support of charity initiative Fashion Targets Breast Cancer this year with the launch of a limited edition t-shirt, available online and instore nationwide.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter J Parker, MD Po Box 5108, Glendale, CA 91221-2108 Ph: (310) 276-2400 | Peter J Parker, MD 1100 W Glenoaks Blvd, Glendale, CA 91202-2606 Ph: (818) 546-2626 |
News Archive
MacroGenics, Inc., a privately held biotechnology company that develops next generation antibody therapeutics, announced today that it will receive a milestone payment from Boehringer Ingelheim.
Cardiovascular disease (CVD) is the major cause of death among middle-aged adults around the world; however, in high-income countries deaths from cancer have become twice as frequent as those from CVD.
"We have analysed emotional traits of low intensity. In this context, the higher the negative emotional traits are, the fewer risks taken by the bodies managed by the directors", Juan Bautista Delgado Garc-a, co-author of the study and researcher at UBU declares to SINC.
Topshop is delighted to announce its continued support of charity initiative Fashion Targets Breast Cancer this year with the launch of a limited edition t-shirt, available online and instore nationwide.
Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.
› Verified 3 days ago
Dr. Marine Demirjian, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1131 N Pacific Ave, Glendale, CA 91202 Phone: 818-558-5828 Fax: 888-717-1542 |